HEPATITIS-B VIRUS CORE PROTEIN MUTATIONS ARE CONCENTRATED IN B-CELL EPITOPES IN PROGRESSIVE DISEASE AND IN T-HELPER CELL EPITOPES DURING CLINICAL REMISSION
Wf. Carman et al., HEPATITIS-B VIRUS CORE PROTEIN MUTATIONS ARE CONCENTRATED IN B-CELL EPITOPES IN PROGRESSIVE DISEASE AND IN T-HELPER CELL EPITOPES DURING CLINICAL REMISSION, The Journal of infectious diseases, 175(5), 1997, pp. 1093-1100
The distribution and temporal and clinical features of amino acid subs
titutions of the core protein of hepatitis B (HB) virus were analyzed,
using at least 2 sequential samples from 27 patients. Six patients se
roconverted from HBe antigen (HBeAg)-positive to anti-HBe-positive (3
went into remission), and 21 were continuously anti-HBe positive with
progressive hepatitis. Precore mutations, which terminate HBeAg transl
ation, all appeared by the second sample. Most core mutations occurred
between the first and second samples; significantly fewer occurred af
ter the second, In seroconverters who went into remission, mutations o
ccurred in the T helper epitope from aa 50 to 69 (P = .00045); for ant
i-HBe-positive patients with ongoing disease, mutations occurred in B
cell epitopes (P = .0007 for aa 74-83). An ineffective anti-HBc B cell
response accounts for ongoing disease and selection of mutations afte
r seroconversion, In those who remit, mutations in the major T helper
epitope allow immune escape, thus minimizing immune-mediated hepatitis
.